KD Logo

Myriad Genetics, Inc [MYGN] Records 50-Day SMA of $24.76

ZOM Stock

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Myriad Genetics, Inc shares valued at $343,950 were sold by DIAZ PAUL J on Oct 11 ’24. At $22.93 per share, DIAZ PAUL J sold 15,000 shares. The insider’s holdings dropped to 962,378 shares worth approximately $17.01 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, DIAZ PAUL J purchased 15,000 shares, netting a total of over 343,950 in proceeds.

Before that, Ancona Margaret had added 11,538 shares to its account. In a trade valued at $321,019, the Officer bought Myriad Genetics, Inc shares for $27.82 each.

As published in their initiating research note from Morgan Stanley on September 19, 2024, Myriad Genetics, Inc [MYGN] has been an Equal-weight and the price target has been revised to $32. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in late August. As of June 27, 2024, Scotiabank has initiated its “Sector outperform” rating for MYGN.

Analyzing MYGN Stock Performance

During the last five days, there has been a drop of approximately -19.54%. Over the course of the year, Myriad Genetics, Inc shares have dropped approximately -7.68%. Shares of the company reached a 52-week high of $29.30 on 09/18/24 and a 52-week low of $16.86 on 11/01/24. A 50-day SMA is recorded $24.76, while a 200-day SMA reached $23.76. Nevertheless, trading volume fell to 0.94 million shares from 1.45 million shares the previous day.

Support And Resistance Levels for Myriad Genetics, Inc (MYGN)

According to the 24-hour chart, there is a support level at 17.35, which, if violated, would cause prices to drop to 17.04. In the upper region, resistance lies at 18.20. The next price resistance is at 18.74. RSI (Relative Strength Index) is 22.26 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.99, which suggests the price will decrease in the coming days. Percent R is at 87.52%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular